Literature DB >> 26659577

Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.

Michael X Henderson1,2,3, Gregory S Wirak1,2, Yong-Quan Zhang1,2, Feng Dai4, Stephen D Ginsberg5,6, Natalia Dolzhanskaya7, John F Staropoli8,9,10, Peter C G Nijssen11, TuKiet T Lam12, Amy F Roth13, Nicholas G Davis13, Glyn Dawson14, Milen Velinov15,7, Sreeganga S Chandra16,17,18,19.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) are a group of inherited neurodegenerative disorders with lysosomal pathology (CLN1-14). Recently, mutations in the DNAJC5/CLN4 gene, which encodes the presynaptic co-chaperone CSPα were shown to cause autosomal-dominant NCL. Although 14 NCL genes have been identified, it is unknown if they act in common disease pathways. Here we show that two disease-associated proteins, CSPα and the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (PPT1/CLN1) are biochemically linked. We find that in DNAJC5/CLN4 patient brains, PPT1 is massively increased and mis-localized. Surprisingly, the specific enzymatic activity of PPT1 is dramatically reduced. Notably, we demonstrate that CSPα is depalmitoylated by PPT1 and hence its substrate. To determine the consequences of PPT1 accumulation, we compared the palmitomes from control and DNAJC5/CLN4 patient brains by quantitative proteomics. We discovered global changes in protein palmitoylation, mainly involving lysosomal and synaptic proteins. Our findings establish a functional link between two forms of NCL and serve as a springboard for investigations of NCL disease pathways.

Entities:  

Keywords:  Cysteine-string protein alpha (CSPα); Neurodegeneration; Neuronal ceroid lipofuscinosis (NCL); Palmitoyl-protein thioesterase 1 (PPT1); Palmitoylation

Mesh:

Substances:

Year:  2015        PMID: 26659577      PMCID: PMC4791186          DOI: 10.1007/s00401-015-1512-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  40 in total

1.  A trimeric protein complex functions as a synaptic chaperone machine.

Authors:  S Tobaben; P Thakur; R Fernández-Chacón; T C Südhof; J Rettig; B Stahl
Journal:  Neuron       Date:  2001-09-27       Impact factor: 17.173

2.  The synaptic vesicle protein CSP alpha prevents presynaptic degeneration.

Authors:  Rafael Fernández-Chacón; Markus Wölfel; Hiroshi Nishimune; Lucia Tabares; Frank Schmitz; Manuel Castellano-Muñoz; Christian Rosenmund; Maria L Montesinos; Joshua R Sanes; Ralf Schneggenburger; Thomas C Südhof
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

3.  Case records of the Massachusetts General Hospital. Case 8-2011. A 32-year-old woman with seizures and cognitive decline.

Authors:  Katherine B Sims; Andrew J Cole; Janet C Sherman; Paul A Caruso; Matija Snuderl
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

Review 4.  Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.

Authors:  Varun Warrier; Mariana Vieira; Sara E Mole
Journal:  Biochim Biophys Acta       Date:  2013-03-28

5.  A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL.

Authors:  O P van Diggelen; J L Keulemans; B Winchester; I L Hofman; S L Vanhanen; P Santavuori; Y V Voznyi
Journal:  Mol Genet Metab       Date:  1999-04       Impact factor: 4.797

6.  Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease.

Authors:  O P van Diggelen; S Thobois; C Tilikete; M T Zabot; J L Keulemans; P A van Bunderen; P E Taschner; M Losekoot; Y V Voznyi
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

7.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

Review 8.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

9.  Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing.

Authors:  Laura Ahtiainen; Kaisu Luiro; Maria Kauppi; Jaana Tyynelä; Outi Kopra; Anu Jalanko
Journal:  Exp Cell Res       Date:  2006-03-20       Impact factor: 3.905

10.  Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis.

Authors:  Bruno A Benitez; David Alvarado; Yefei Cai; Kevin Mayo; Sumitra Chakraverty; Joanne Norton; John C Morris; Mark S Sands; Alison Goate; Carlos Cruchaga
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

View more
  32 in total

1.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

Review 2.  Protein depalmitoylases.

Authors:  Sang Joon Won; Melanie Cheung See Kit; Brent R Martin
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-14       Impact factor: 8.250

3.  Hsp110 mitigates α-synuclein pathology in vivo.

Authors:  Yumiko V Taguchi; Erica L Gorenberg; Maria Nagy; Drake Thrasher; Wayne A Fenton; Laura Volpicelli-Daley; Arthur L Horwich; Sreeganga S Chandra
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-04       Impact factor: 11.205

4.  Identification of substrates of palmitoyl protein thioesterase 1 highlights roles of depalmitoylation in disulfide bond formation and synaptic function.

Authors:  Erica L Gorenberg; Sofia Massaro Tieze; Betül Yücel; Helen R Zhao; Vicky Chou; Gregory S Wirak; Susumu Tomita; TuKiet T Lam; Sreeganga S Chandra
Journal:  PLoS Biol       Date:  2022-03-31       Impact factor: 8.029

Review 5.  Current knowledge of protein palmitoylation in gliomas.

Authors:  Feng Tang; Zhenyuan Liu; Xi Chen; Jinzhou Yang; Zefen Wang; Zhiqiang Li
Journal:  Mol Biol Rep       Date:  2022-08-31       Impact factor: 2.742

Review 6.  Synaptic metabolism: a new approach to inborn errors of neurotransmission.

Authors:  Alba Tristán-Noguero; Àngels García-Cazorla
Journal:  J Inherit Metab Dis       Date:  2018-07-16       Impact factor: 4.982

Review 7.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

Review 8.  Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis.

Authors:  Nima Naseri; Manu Sharma; Milen Velinov
Journal:  Clin Genet       Date:  2020-08-26       Impact factor: 4.438

9.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

Review 10.  DNAJ Proteins in neurodegeneration: essential and protective factors.

Authors:  Christina Zarouchlioti; David A Parfitt; Wenwen Li; Lauren M Gittings; Michael E Cheetham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.